153 related articles for article (PubMed ID: 35577490)
21. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
Altmann A; Ng B; Landau SM; Jagust WJ; Greicius MD;
Brain; 2015 Dec; 138(Pt 12):3734-46. PubMed ID: 26419799
[TBL] [Abstract][Full Text] [Related]
22. Relationship between F-18 florbetapir uptake in occipital lobe and neurocognitive performance in Alzheimer's disease.
Thientunyakit T; Thongpraparn T; Sethanandha C; Yamada T; Kimura Y; Muangpaisan W; Ishii K
Jpn J Radiol; 2021 Oct; 39(10):984-993. PubMed ID: 34019227
[TBL] [Abstract][Full Text] [Related]
23. In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
Baghel V; Tripathi M; Parida G; Gupta R; Yadav S; Kumar P; Dey AB; Damle NA; Kumar R; Bal C
Clin Nucl Med; 2019 Nov; 44(11):e597-e601. PubMed ID: 31584490
[TBL] [Abstract][Full Text] [Related]
24. Use of florbetapir-PET for imaging beta-amyloid pathology.
Clark CM; Schneider JA; Bedell BJ; Beach TG; Bilker WB; Mintun MA; Pontecorvo MJ; Hefti F; Carpenter AP; Flitter ML; Krautkramer MJ; Kung HF; Coleman RE; Doraiswamy PM; Fleisher AS; Sabbagh MN; Sadowsky CH; Reiman EP; Zehntner SP; Skovronsky DM;
JAMA; 2011 Jan; 305(3):275-83. PubMed ID: 21245183
[TBL] [Abstract][Full Text] [Related]
25. Extracardiac
Wagner T; Page J; Burniston M; Skillen A; Ross JC; Manwani R; McCool D; Hawkins PN; Wechalekar AD
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1129-1138. PubMed ID: 29651545
[TBL] [Abstract][Full Text] [Related]
26.
Ottoy J; Verhaeghe J; Niemantsverdriet E; De Roeck E; Wyffels L; Ceyssens S; Van Broeckhoven C; Engelborghs S; Stroobants S; Staelens S
Alzheimers Dement; 2019 Sep; 15(9):1172-1182. PubMed ID: 31405824
[TBL] [Abstract][Full Text] [Related]
27. Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?
Paghera B; Altomare D; Peli A; Morbelli S; Buschiazzo A; Bauckneht M; Giubbini R; Rodella C; Camoni L; Boccardi M; Festari C; Muscio C; Padovani A; Frisoni GB; Guerra UP
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):414-421. PubMed ID: 31089074
[TBL] [Abstract][Full Text] [Related]
28. Assessment of perfusion deficit with early phases of [
Völter F; Beyer L; Eckenweber F; Scheifele M; Bui N; Patt M; Barthel H; Katzdobler S; Palleis C; Franzmeier N; Levin J; Perneczky R; Rauchmann BS; Sabri O; Hong J; Cumming P; Rominger A; Shi K; Bartenstein P; Brendel M
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1384-1394. PubMed ID: 36572740
[TBL] [Abstract][Full Text] [Related]
29. Coupled Imaging with [
Chiaravalloti A; Castellano AE; Ricci M; Barbagallo G; Sannino P; Ursini F; Karalis G; Schillaci O
Mol Imaging Biol; 2018 Aug; 20(4):659-666. PubMed ID: 29404839
[TBL] [Abstract][Full Text] [Related]
30. Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET.
Jeong YJ; Yoon HJ; Kang DY
Medicine (Baltimore); 2017 Dec; 96(48):e9042. PubMed ID: 29310421
[TBL] [Abstract][Full Text] [Related]
31. Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.
Tiepolt S; Hesse S; Patt M; Luthardt J; Schroeter ML; Hoffmann KT; Weise D; Gertz HJ; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1700-9. PubMed ID: 27026271
[TBL] [Abstract][Full Text] [Related]
32. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
[TBL] [Abstract][Full Text] [Related]
33. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
[TBL] [Abstract][Full Text] [Related]
34. Quantitative [
Khor YM; Cuddy S; Harms HJ; Kijewski MF; Park MA; Robertson M; Hyun H; Di Carli MF; Bianchi G; Landau H; Yee A; Sanchorawala V; Ruberg FL; Liao R; Berk J; Falk RH; Dorbala S
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1998-2009. PubMed ID: 31807884
[TBL] [Abstract][Full Text] [Related]
35. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
[TBL] [Abstract][Full Text] [Related]
36. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
[TBL] [Abstract][Full Text] [Related]
37. Imaging characteristics and safety of florbetapir (¹⁸F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer's disease.
Namiki C; Takita Y; Iwata A; Momose T; Senda M; Okubo Y; Joshi AD; Lu M; Agbulos A; Breault C; Pontecorvo MJ
Ann Nucl Med; 2015 Aug; 29(7):570-81. PubMed ID: 25943346
[TBL] [Abstract][Full Text] [Related]
38. A deep learning model for generating [
Sanaat A; Boccalini C; Mathoux G; Perani D; Frisoni GB; Haller S; Montandon ML; Rodriguez C; Giannakopoulos P; Garibotto V; Zaidi H
Eur J Nucl Med Mol Imaging; 2024 Jun; ():. PubMed ID: 38861183
[TBL] [Abstract][Full Text] [Related]
39. Brain 18 F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation.
Cistaro A; Quartuccio N; Cassalia L; Vai D; Guerra UP; Atzori C; Rainero I; Imperiale D
Alzheimer Dis Assoc Disord; 2022 Oct-Dec 01; 36(4):347-349. PubMed ID: 34132671
[TBL] [Abstract][Full Text] [Related]
40. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
